HF
BIO icon

HRT Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

HRT Financial’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,556
Closed -$13M – 4223
2026
Q1 		$13M Buy
+46,556
New +$13.4M 0.03% 516
2025
Q4 		– Sell
-25,739
Closed -$7.22M – 3203
2025
Q3 		$7.22M Sell
25,739
-49,079
-66% -$13.4M 0.03% 513
2025
Q2 		$18.1M Buy
74,818
+16,085
+27% +$3.8M 0.08% 167
2025
Q1 		$14.3M Buy
+58,733
New +$17.7M 0.09% 168
2024
Q4 		– Sell
-44,520
Closed -$14.9M – 2449
2024
Q3 		$14.9M Buy
+44,520
New +$14.1M 0.07% 172
2024
Q2 		– Sell
-2,053
Closed -$710K – 2237
2024
Q1 		$710K Buy
2,053
+355
+21% +$117K ﹤0.01% 1066
2023
Q4 		$548K Sell
1,698
-16,447
-91% -$5.16M ﹤0.01% 1308
2023
Q3 		$6.5M Buy
18,145
+15,320
+542% +$5.91M 0.06% 215
2023
Q2 		$1.07M Sell
2,825
-3,406
-55% -$1.39M 0.01% 915
2023
Q1 		$2.98M Buy
6,231
+4,856
+353% +$2.27M 0.04% 430
2022
Q4 		$578K Buy
1,375
+39
+3% +$15.7K 0.01% 1316
2022
Q3 		$557K Buy
+1,336
New +$666K 0.01% 1365
2022
Q2 		– Sell
-933
Closed -$525K – 2946
2022
Q1 		$525K Sell
933
-4,572
-83% -$2.76M ﹤0.01% 1602
2021
Q4 		$4.16M Buy
+5,505
New +$4.12M 0.02% 352
2021
Q3 		– Sell
-4,951
Closed -$3.19M – 3284
2021
Q2 		$3.19M Buy
+4,951
New +$3.01M 0.03% 430
2021
Q1 		– Sell
-1,604
Closed -$935K – 2696
2020
Q4 		$935K Buy
+1,604
New +$913K 0.02% 714
2020
Q3 		– Sell
-22,444
Closed -$10.1M – 1900
2020
Q2 		$10.1M Buy
+22,444
New +$9.9M 0.3% 63

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HRT Financial's BIO Position: Q2 2026 in Review

HRT Financial sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 46,556 shares — an estimated $13M sold.

HRT Financial first reported a position in BIO in Q2 2020 and held it in 17 quarters. The position peaked at $18.1M in Q2 2025. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • HRT Financial reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 46,556 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $13M.
  • HRT Financial first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 17 quarters.
  • HRT Financial's Bio-Rad Laboratories Class A position peaked at $18.1M in Q2 2025.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.